Jasper Therapeutics Inc
NASDAQ:JSPR
Jasper Therapeutics Inc
NASDAQ:JSPR
Price:
21.42 USD
2.39%
Updated:
May 15, 2024
Balance Sheet
Balance Sheet Decomposition
Jasper Therapeutics Inc
Jasper Therapeutics Inc
| Current Assets | 88.9m |
| Cash & Short-Term Investments | 86.9m |
| Receivables | 250k |
| Other Current Assets | 1.8m |
| Non-Current Assets | 6m |
| PP&E | 4.2m |
| Other Non-Current Assets | 1.8m |
| Current Liabilities | 12.4m |
| Accounts Payable | 4.1m |
| Accrued Liabilities | 7.9m |
| Other Current Liabilities | 317k |
| Non-Current Liabilities | 4.1m |
| Other Non-Current Liabilities | 4.1m |
Balance Sheet
Jasper Therapeutics Inc
Jasper Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
27
|
20
|
85
|
38
|
87
|
|
| Cash Equivalents |
27
|
20
|
85
|
38
|
87
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
3
|
2
|
|
| Total Current Assets |
27
|
21
|
88
|
42
|
89
|
|
| PP&E Net |
0
|
2
|
5
|
5
|
4
|
|
| PP&E Gross |
0
|
2
|
5
|
5
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
1
|
2
|
|
| Total Assets |
27
N/A
|
23
-14%
|
94
+301%
|
48
-48%
|
95
+96%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
4
|
2
|
4
|
|
| Accrued Liabilities |
1
|
3
|
4
|
5
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
4
|
8
|
7
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
4
|
11
|
16
|
5
|
4
|
|
| Total Liabilities |
6
N/A
|
15
+140%
|
24
+65%
|
12
-49%
|
16
+33%
|
|
| Equity | ||||||
| Common Stock |
26
|
44
|
0
|
0
|
0
|
|
| Retained Earnings |
5
|
37
|
67
|
105
|
170
|
|
| Additional Paid In Capital |
0
|
2
|
137
|
141
|
248
|
|
| Total Equity |
21
N/A
|
9
-59%
|
70
+698%
|
36
-48%
|
78
+118%
|
|
| Total Liabilities & Equity |
27
N/A
|
23
-14%
|
94
+301%
|
48
-48%
|
95
+96%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
38
|
38
|
38
|
38
|
11
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
